Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues.
暂无分享,去创建一个
A. Lustig | A. Weeraratna | D. Taub | K. Becker | T. Beach | D. Walker | William W Wood | G. Maher | M. Wade | D. Bertak | Audrey D. Kalehua | I. Deleon | Gregory W. Maher
[1] S. Paludan,et al. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. , 2006, The Journal of general virology.
[2] C. Pert,et al. Chemokine receptor 5 antagonist d-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease , 2005, Neuroscience.
[3] C. Eckman,et al. Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention , 2005 .
[4] Xiang-Jiao Yang,et al. Association with Class IIa Histone Deacetylases Upregulates the Sumoylation of MEF2 Transcription Factors , 2005, Molecular and Cellular Biology.
[5] S. Gibbs,et al. Increased CCL27–CCR10 expression in allergic contact dermatitis: implications for local skin memory , 2004, The Journal of pathology.
[6] M. Bittner,et al. Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome , 2004, Oncogene.
[7] D. Holtzman,et al. Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[8] Mark P. Mattson,et al. Infectious agents and age-related neurodegenerative disorders , 2003, Ageing Research Reviews.
[9] B. Gesser,et al. Expression of the T‐helper 2‐specific chemokine receptor CCR4 on CCR10‐positive lymphocytes in atopic dermatitis skin but not in psoriasis skin , 2003, The British journal of dermatology.
[10] L. Marlow,et al. Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme* , 2003, The Journal of Biological Chemistry.
[11] M. Ball,et al. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.
[12] B. Hyman,et al. LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes. , 2002, Brain research. Molecular brain research.
[13] Pierre J Magistretti,et al. Aquaporins in Brain: Distribution, Physiology, and Pathophysiology , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] H. Soto,et al. CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.
[15] James J. Campbell,et al. CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin , 2001, The Journal of experimental medicine.
[16] J M Lee,et al. A gene expression profile of Alzheimer's disease. , 2001, DNA and cell biology.
[17] C. Eckman,et al. Degradation of the Alzheimer's Amyloid β Peptide by Endothelin-converting Enzyme* , 2001, The Journal of Biological Chemistry.
[18] K Kosaka,et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. , 2001, Biochemical and biophysical research communications.
[19] B. Hyman,et al. Elevation of LDL Receptor‐Related Protein Levels via Ligand Interactions in Alzheimer Disease and In Vitro , 2001, Journal of neuropathology and experimental neurology.
[20] A. Czernik,et al. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique , 2001, Neuroscience Letters.
[21] V. Álvarez,et al. Variation in the LRP-associated protein gene (LRPAP1) is associated with late-onset Alzheimer disease. , 2001, American journal of medical genetics.
[22] V. Bond,et al. Involvement of Protein Kinase C in HIV‐1 gpl20‐Induced Apoptosis in Primary Endothelium , 2000, Journal of acquired immune deficiency syndromes.
[23] D. Strickland,et al. LRP in Alzheimer's disease: friend or foe? , 2000, The Journal of clinical investigation.
[24] R. Katzman.,et al. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. , 2000, The Journal of clinical investigation.
[25] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[26] E. Butcher,et al. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. , 2000, Current opinion in immunology.
[27] Weiqi Wang,et al. Cutting Edge: The Orphan Chemokine Receptor G Protein-Coupled Receptor-2 (GPR-2, CCR10) Binds the Skin-Associated Chemokine CCL27 (CTACK/ALP/ILC)1 , 2000, The Journal of Immunology.
[28] R. Itzhaki,et al. Herpes simplex virus type 1 and Alzheimer’s disease , 1999, Neurobiology of Aging.
[29] J. Poirier,et al. The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease , 1999, Neuroscience Letters.
[30] Takayuki Itoh,et al. Microglia Express CCR5, CXCR4, and CCR3, but of These, CCR5 Is the Principal Coreceptor for Human Immunodeficiency Virus Type 1 Dementia Isolates , 1999, Journal of Virology.
[31] R Brookmeyer,et al. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.
[32] J. Woo,et al. Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese , 1998, Neuroscience Letters.
[33] H. Braak,et al. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis , 1996, Acta Neuropathologica.
[34] H. Braak,et al. Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.
[35] A. Haase,et al. Human herpes virus infections and Alzheimer's disease , 1990, Neuropathology and applied neurobiology.
[36] G. Bu,et al. LRP and Alzheimer's Disease , 2005, Reviews in the neurosciences.
[37] C. Eckman,et al. Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. , 2005, Biochemical Society transactions.
[38] P. Ghezzi,et al. Positive and negative regulation of APP amyloidogenesis by sumoylation , 2003 .
[39] B T Hyman,et al. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. , 1999, Journal of neurovirology.